Bicycle Therapeutics (BCYC) Operating Leases (2019 - 2026)

Bicycle Therapeutics (BCYC) has 8 years of Operating Leases data on file, last reported at $13.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 431.77% year-over-year to $13.9 million; the trailing twelve-month figure through Mar 2026 stood at $13.9 million (up 431.77% YoY), and the FY2025 full-year result was $14.1 million, up 253.28% from the prior year.
• Operating Leases for Q1 2026 stood at $13.9 million, down from $14.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $14.4 million in Q1 2023 and bottomed at $981000.0 in Q3 2025.
• The 5-year median for Operating Leases is $10.4 million (2023), against an average of $9.0 million.
• The widest annual swing landed in 2025, when Operating Leases tumbled 82.27%; it then surged 431.77% in 2026.
• A 5-year view of Operating Leases shows it stood at $10.9 million in 2022, then decreased by 13.81% to $9.4 million in 2023, then tumbled by 57.47% to $4.0 million in 2024, then soared by 253.28% to $14.1 million in 2025, then retreated by 1.57% to $13.9 million in 2026.
• The last three Operating Leases figures came in at $13.9 million (Q1 2026), $14.1 million (Q4 2025), and $981000.0 (Q3 2025), per Business Quant data.

Peer Comparison